Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women

Documenti analoghi

• Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis
  di: Dumond, Julie B., et al.
  Pubblicazione: (2007)
• Antiretroviral prophylaxis: a defining moment for HIV prevention
  di: Abdool Karim, Salim S, et al.
  Pubblicazione: (2011)
• Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women
  di: Kimone Leigh Fisher, et al.
  Pubblicazione: (2020-07-01)
• HIV Disease Progression in Seroconvertors from the CAPRISA 004 Tenofovir Gel Pre-exposure Prophylaxis Trial
  di: GARRETT, Nigel J, et al.
  Pubblicazione: (2015)
• Genital tenofovir concentrations correlate with protection against HIV infection in the CAPRISA 004 trial: Importance of adherence for microbicide effectiveness
  di: Kashuba, Angela DM, et al.
  Pubblicazione: (2015)